


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
THC
Tenet Healthcare
$196.57
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Chart
$206.91 (-5.00%)
$178.03 (+10.41%)
$167.58 (+17.30%)
$147.92 (+32.89%)
THC has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

THC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
THC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
THC Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is THC current stock price?
What are THC stock strengths?
What risks are associated with THC stock?
When is THC next earnings report?
What is THC market cap and volume?
What is THC's current Stock IQ?
Should I buy THC stock right now?
Is THC a Strong Buy right now?
What does a 'Strong Buy' rating mean for THC?
What does a 'Strong Sell' rating mean for THC?
What factors influence THC's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.77%
+4.62%
-3.25%
-3.25%
+9.71%
THC
Tenet Healthcare
Current Price
$196.57
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market

Chart
$206.91 (-5.00%)
$178.03 (+10.41%)
$167.58 (+17.30%)
$147.92 (+32.89%)
THC Analysts Opinion
THC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
THC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
THC Street Sentiment is extremely bullish and have positive views on the near-term outlook
THC has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
THC Latest Analysis
Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat. THCs Q3 profit beats estimates on higher revenues and strong segment growth but rising costs drag shares lower.
Mon Nov 10, 2025
Tuesday Sector Leaders: Hospital & Medical Practitioners Rubber & Plastics. In trading on Tuesday hospital &. medical practitioners shares were relative leaders up on the day by about 1.4%. Leading the group were shares of AdaptHealth up about 11.4% and shares of Tenet Healthcare up about 3.8% on the day.Also showing relative strength are rubbe
Tue Nov 4, 2025
Truist Securities Reiterates Tenet Healthcare (THC) Buy Recommendation. Fintel reports that on November 3 2025 Truist Securities reiterated coverage of Tenet Healthcare (NYSE:THC) with a Buy recommendation. Analyst Price Forecast Suggests 7.04% Upside
Tue Nov 4, 2025
Tenet Healthcare Announces Private Offerings Of Notes To Refinance $2 Bln In Outstanding Notes . (RTTNews) - Tenet Healthcare Corp. (THC) Monday announced private placement offerings of $1.5 billion of new senior secured first lien notes due 2032 and $0.5 billion of new senior notes due 2033 to refinance $2.0 billion of its currently outstanding notes.
Mon Nov 3, 2025
Tenet Healthcare to raise $2 billion in notes for debt refinancing.
Mon Nov 3, 2025
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates. Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Tue Oct 28, 2025
Tenet Healthcare Corp. Q3 Profit Decreases But Beats Estimates . (RTTNews) - Tenet Healthcare Corp. (THC) revealed a profit for third quarter that Decreased from the same period last year but beat the Street estimates.
Tue Oct 28, 2025
Tenet Healthcare beats Q3 estimates raises outlook.
Tue Oct 28, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.